Leukemia Among Cancer Types Fueled by Obesity

In an analysis of 5.24 million patients, researchers found 'significant associations' between increasing body size and 10 common cancer subtypes.

"We estimated that a 1 kg (2.2 lbs.) per meter-squared population-wide increase in BMI would result in 3,790 additional annual UK patients developing one of the 10 cancers positively associated with BMI," wrote Krishnan Bhaskaran, MSc, PhD, of the London School of Hygiene and Tropical Medicine.

Bhaskaran and colleagues analyzed data from the Clinical Practice Research Datalink (CPRD), a database that includes primary care records for about nine percent of the British population.

The cancer subtypes found to have varying associations with body mass index (BMI) include:

  • Uterine cancer
  • Gallbladder cancer
  • Kidney cancer
  • Cervical cancer
  • Thyroid cancer
  • Leukemia
  • Liver cancer
  • Colon cancer
  • Ovarian cancer
  • Postmenopausal breast cancer

Writing in an accompanying commentary, Peter T. Campbell PhD of the American Cancer Society called obesity, "an avoidable cause of cancer."

"We have sufficient evidence that obesity is an important cause of unnecessary suffering and death from many forms of cancer, in addition to the well-recognized increased risks of mortality and morbidity from many other causes," added Campbell. "Research strategies that identify population-wide or community-based interventions and policies that effectively reduce overweight and obesity should be particularly encouraged and supported."

The team reported their findings in The Lancet.

Source: MedPage Today

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap